ARDX - Rega marang dodolan Ardelyx Inc

Simbol lan logo merek Ardelyx Inc (ARDX)

Ardelyx, Inc. (ARDX) exhibits high crisis resilience due to stable demand for nephrology drugs. The P/S ratio trend confirms this potential, with the metric currently reaching the level of 1.70. However, promotional budget deficits and reliance on US government registries create certain challenges. Meanwhile, drug exclusivity ensures a powerful capital inflow and steady growth in operating profit.

Rasio rega marang pendapatan: ardelyx.com (ARDX) kanggo 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Ardelyx Pharma (ARDX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Rega bursa ardelyx.com|ARDX - Target konsensus
- statistik kapitalisasi pasar:
Nilai pasar Ardelyx Pharma|ARDX - Nilai Perusahaan
- data nilai buku modal saham:
Nilai Buku saben Saham Ardelyx|ARDX - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku ardelyx.com|ARDX - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas Ardelyx, Inc.|ARDX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Ardelyx Corp|ARDX - Utang perusahaan|Rasio utang marang kapitalisasi buku Ardelyx Pharma|ARDX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak Ardelyx|Rasio likuiditas darurat ardelyx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ARDX - Penghasilan resik|Penghasilan resik sing dikarepake Ardelyx, Inc.|ARDX - Pangali P/E|Kapitalisasi marang proyeksi bathi Ardelyx Inc|ARDX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Ardelyx Pharma|ARDX - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Ardelyx|ARDX - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan ardelyx.com|ARDX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Ardelyx, Inc.
- data total pendapatan lan volume dodolan:
ARDX - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan ardelyx.com|ARDX - Multiplikator P/S|Kapitalisasi marang prakiraan pendapatan Ardelyx Pharma
Analisis fundamental perusahaan:ardelyx.com ARDX
Produk sing diprodhuksi Ardelyx

Investors are balancing the potential for share price appreciation against the risk of capital stagnation when selecting an entry point. This price-to-sales ratio compares market capitalization with actual sales volume to reflect demand phases; for Ardelyx, Inc. (ARDX), a decline in this multiple amid the exclusivity of its kidney and gastrointestinal drugs signals an undervaluation of its stable cash flow.

Karo sapa Ardelyx, Inc. saingan

TVTX - Rega marang dodolan|ProKidney - Kapitalisasi marang pendapatan|Akebia Therapeutics Inc (AKBA) - Rega marang dodolan|Cara Pharma - Multiplikator P/S|DMAC - Multiplikator P/S|Unicycive Therapeutics (UNCY) - Rasio rega marang pendapatan|rockwellmed.com - Rasio kapitalisasi pasar marang pendapatan|CVKD (Cadrenal Therapeutics, Inc.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan CDT (Conduit Pharmaceuticals Inc)|Multiplikator P/S CALT|RNLX - Rega marang dodolan|Rasio rega marang pendapatan ZyVersa Therapeutics, Inc. ZVSA